The beneficial role of evolocumab on the vascular function of high cv risk subjects: Beyond low-density lipoprotein cholesterol lowering. (August 2021) - Silla, A.; Fogacci, F.; Punzo, A.; Calabria, D.; Guardigli, M.; Cicero, A.F.G.; Caliceti, C.